Glickman R M, Green P H
Proc Natl Acad Sci U S A. 1977 Jun;74(6):2569-73. doi: 10.1073/pnas.74.6.2569.
The major apoprotein of rat mesenteric lymph chylomicrons has been isolated and characterized and shown to be identical to apoprotein A1 (apo A1) isolated from serum high density lipoprotein (HDL). During intestinal lipid absorption, active synthesis of apo A1 was demonstrated by radioactive amino acid incorporation into lymph chylomicron A1 as well as lymph HDL. Immunofluorescence studies of intestinal epithelium demonstrated a marked increase in apo A1 fluorescence, confirming an active synthesis of this apoprotein during lipid absorption. Quantitative immunoelectrophoretic methods were used to measure apo A1 in lymph and peripheral blood during various conditions designed to estimate the quantitative importance of intestinal apo A1 to the levels of circulating lipoproteins. During lipid feeding there was an increase in lymph apo A1 that was associated with lymph lipoproteins (50%) of density less than 1.006 g/ml whereas in basal lymph most apo A1 (85%) was in the lipoproteins of density greater than 1.006 g/ml. Lipid feeding in animals without lymph fistulas resulted in a significant increase in serum apo A1 levels; biliary diversion, designed to eliminate intestinal lipoproteins of density less than 1.006 g/ml, resulted in a significant decrease in serum apo A1 levels. These studies demonstrate that the intestine actively synthesizes apo A1 and is a significant source of this apoprotein for circulating lipoproteins.
大鼠肠系膜淋巴乳糜微粒的主要载脂蛋白已被分离、鉴定,结果表明它与从血清高密度脂蛋白(HDL)中分离出的载脂蛋白A1(apo A1)相同。在肠道脂质吸收过程中,通过放射性氨基酸掺入淋巴乳糜微粒A1以及淋巴HDL中,证实了apo A1的活跃合成。对肠上皮的免疫荧光研究显示apo A1荧光显著增加,证实了在脂质吸收过程中这种载脂蛋白的活跃合成。采用定量免疫电泳方法,在各种旨在评估肠道apo A1对循环脂蛋白水平的定量重要性的条件下,测量淋巴和外周血中的apo A1。在给予脂质期间,淋巴apo A1增加,且与密度小于1.006 g/ml的淋巴脂蛋白相关(50%),而在基础淋巴中,大多数apo A1(85%)存在于密度大于1.006 g/ml的脂蛋白中。对无淋巴瘘的动物给予脂质导致血清apo A1水平显著升高;旨在消除密度小于1.006 g/ml的肠道脂蛋白的胆管改道,导致血清apo A1水平显著降低。这些研究表明,肠道能活跃地合成apo A1,并且是循环脂蛋白中这种载脂蛋白的重要来源。